Sign in

CIK 0001157601 · Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
(267) 824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
  1. 8-K Event Other events
  2. UPLOAD Other SEC-generated Letter
  3. 4 Open-market sale Senior VP, Chief Pharma Dev. sold 4,000 shares at an average $235.50 ($942,000)
  4. 4 Open-market buy Director bought 101,792 shares at an average $221.20 ($22,516,577)
  5. 4 Open-market buy Director bought 34,578 shares at an average $218.31 ($7,548,616)
  6. 4 Open-market sale Senior VP, Chief Pharma Dev. sold 3,800 shares at an average $222.82 ($846,700)
  7. CORRESP Other Correspondence Between Filers and SEC Staff
  8. SC 13D/A Stake Beneficial Ownership Report
  9. 4 Gift Director gave 3,557 shares (gift)
  10. CORRESP Other Correspondence Between Filers and SEC Staff
  11. 4 Open-market sale SVP and General Counsel sold 2,800 shares at an average $221.89 ($621,294)
  12. 4 Open-market sale SVP and General Counsel sold 7,000 shares at an average $201.50 ($1,410,480)
  13. 4 Grant or award Chief Commercial Officer acquired 7,834 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. UPLOAD Other SEC-generated Letter
  16. 4 Open-market buy Director bought 64,350 shares at an average $188.47 ($12,128,340)
  17. 4 Open-market buy Director bought 67,079 shares at an average $178.11 ($11,947,280)
  18. SC 13D/A Stake Beneficial Ownership Report
  19. 4 Open-market buy Director bought 49,387 shares at an average $158.13 ($7,809,559)
  20. 4 Open-market buy Director bought 107,499 shares at an average $146.99 ($15,801,021)

Page 16 of 62 · 1,224 filings